Dirk Huebner
Director Técnico/Científico/I+D en APTEVO THERAPEUTICS INC. .
Cargos activos de Dirk Huebner
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| APTEVO THERAPEUTICS INC. | Director Técnico/Científico/I+D | - | - |
Historial de carrera de Dirk Huebner
Antiguos cargos conocidos de Dirk Huebner.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| MERSANA THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 27/11/2018 | 30/11/2020 |
Boston Biomedical, Inc.
 Boston Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sumitomo Chemical Co., Ltd., Boston Biomedical, Inc. is a developer of novel cancer therapeutics with the goal of significantly improving patient outcomes. The company is based in Norwood, MA. The company's most advanced research programs are focused on investigational agents that inhibit multiple oncogenic pathways, including cancer stemness pathways, and modifying immune responses. The company was founded by Chiang J. Li. Boston Biomedical was acquired by Sumitomo Pharma Co., Ltd. on April 25, 2012 for $2,630 million. | Corporate Officer/Principal | 01/08/2017 | 01/11/2018 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/08/2017 | 01/08/2017 |
Formación de Dirk Huebner.
| Freie Universität Berlin | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
| Alemania | 2 |
Operativa
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| MERSANA THERAPEUTICS, INC. | Health Technology |
| APTEVO THERAPEUTICS INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Boston Biomedical, Inc.
Boston Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sumitomo Chemical Co., Ltd., Boston Biomedical, Inc. is a developer of novel cancer therapeutics with the goal of significantly improving patient outcomes. The company is based in Norwood, MA. The company's most advanced research programs are focused on investigational agents that inhibit multiple oncogenic pathways, including cancer stemness pathways, and modifying immune responses. The company was founded by Chiang J. Li. Boston Biomedical was acquired by Sumitomo Pharma Co., Ltd. on April 25, 2012 for $2,630 million. | Commercial Services |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Dirk Huebner
- Experiencia
